Medscape: Mild Liver Enzyme Increases Seen in COVID-19 Patients in China
UC digestive diseases expert discusses COVID-19's impact on the liver
Close to 30% of COVID-19 patients presented with mildly elevated liver enzymes in a retrospective study in China. Enzyme levels did not rise significantly during hospitalization and no patients experienced liver failure, however. Kenneth Sherman, MD, PhD, Director of the UC Division of Digestive Diseases and UC Health physician, spoke with journalist Marilynn Larkin about possible liver damage associated with SARS-CoV-2 and how pre-existing liver disease could make individuals more susceptible to infection leading to COVID-19.
Read the entire interview online.
Learn more about Sherman's COVID-19 research.
Featured image at top: Kenneth Sherman, MD, PhD, shown in the UC College of Medicine. Photo/Colleen Kelley/UC Creative + Brand.
Next Lives Here
The University of Cincinnati is classified as a Research 1 institution by the Carnegie Commission and is ranked in the National Science Foundation's Top-35 public research universities. UC's graduate students and faculty investigate problems and innovate solutions with real-world impact. Next Lives Here.
Related Stories
Yahoo! News promotes UC botanist's solution for honeysuckle
February 10, 2026
Yahoo! News shared University of Cincinnati botanist Denis Conover's method for eliminating honeysuckle without using chemicals.
University of Cincinnati Cancer Center names David Gius, MD, PhD, as director
February 10, 2026
Following a highly competitive national search, the University of Cincinnati Cancer Center has appointed David Gius, MD, PhD, as its next director.
Breakthrough UC study sheds light on survival of new neurons in adult brain
February 9, 2026
Research from the University of Cincinnati College of Medicine, recently published in the journal Nature Communications, is revealing how immune cells in the adult brain regulate the generation of new neurons.